AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32921425 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin (MEL) in Parkinson's disease with sleep disorders.
Number of subjects: 11
Study 32921425 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin (MEL) in epileptic patients.
Number of subjects: 11
Study 32921425 — intervention group
Group type: EXPERIMENTAL
Intervention: Light therapy used 12 hours before melatonin treatment.
Number of subjects: 11
Study 32921425 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin (MEL) in primary headache, migraine, and cluster headache.
Number of subjects: 11
Study 32777381 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated bilingual computerized alcohol screening and brief intervention (AB-CASI)
Number of subjects: 820
Study 32777381 — intervention group
Group type: COMPARATOR
Intervention: Standard care (SC)
Number of subjects: 820
Study 32777381 — intervention group
Group type: EXPERIMENTAL
Intervention: AB-CASI
Number of subjects: 820
Study 35588339 — intervention group
Group type: EXPERIMENTAL
Intervention: u-net model for tumor segmentation
Number of subjects: 33
Study 35588339 — intervention group
Group type: EXPERIMENTAL
Intervention: Expert visual ratings
Number of subjects: 33
Study 35588339 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time tumor segmentation
Number of subjects: 33
Study 33128325 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct oral anticoagulants (DOACs)
Number of subjects: 120
Study 33128325 — intervention group
Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 120
Study 35578445 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy of tofogliflozin (20 mg) and pioglitazone (15–30 mg)
Number of subjects: 32
Study 35578445 — intervention group
Group type: COMPARATOR
Intervention: Pioglitazone monotherapy
Number of subjects: 32
Study 32694366 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional Impact Training (FIT)
Number of subjects: 44
Study 32694366 — intervention group
Group type: COMPARATOR
Intervention: Yin Yoga
Number of subjects: 44
Study 32694366 — intervention group
Group type: COMPARATOR
Intervention: Functional Impact Training (FIT) and Yin Yoga
Number of subjects: 44
Study 35078735 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse practitioner-delivered brief intervention (BI)
Number of subjects: 254
Study 35078735 — intervention group
Group type: COMPARATOR
Intervention: Computer-delivered brief intervention (BI)
Number of subjects: 254
Study 35078735 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse practitioner-delivered BI
Number of subjects: 254
Study 32648392 — intervention group
Group type: EXPERIMENTAL
Intervention: Meridian-point acupuncture group
Number of subjects: 140
Study 32648392 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication group (estazolam 1-2 mg per night for 4 weeks)
Number of subjects: 140
Study 32648392 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication group
Number of subjects: 140
Study 34534371 — intervention group
Group type: EXPERIMENTAL
Intervention: Báa nnilah chronic illness self‐management program
Number of subjects: 0
Study 34534371 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 0
Study 33417708 — intervention group
Group type: EXPERIMENTAL
Intervention: Proximity to neighborhood investments (<0.1 mile)
Number of subjects: 676
Study 33417708 — intervention group
Group type: COMPARATOR
Intervention: Farther away from neighborhood investments (>0.1 mile)
Number of subjects: 676
Study 32211798 — intervention group
Group type: EXPERIMENTAL
Intervention: Milk8 (8.8 g milk protein/d, 100 kcal/d)
Number of subjects: 0
Study 32211798 — intervention group
Group type: COMPARATOR
Intervention: Milk/rice (4.4 g milk and 4.4 g rice protein/d, 100 kcal/d)
Number of subjects: 0
Study 32211798 — intervention group
Group type: COMPARATOR
Intervention: Milk4 (4.4 g milk protein/d, 48 kcal/d)
Number of subjects: 0
Study 32211798 — intervention group
Group type: COMPARATOR
Intervention: Control (no protein, 10 kcal/d)
Number of subjects: 0
Study 32211798 — intervention group
Group type: EXPERIMENTAL
Intervention: Milk interventions (general)
Number of subjects: 0
Study 35994240 — intervention group
Group type: EXPERIMENTAL
Intervention: Health education via mobile application
Number of subjects: 214
Study 35994240 — intervention group
Group type: COMPARATOR
Intervention: Face-to-face health education (control group)
Number of subjects: 214
Study 34370858 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultra-long downregulation with GnRH agonist (triptorelin depot) for at least 3 months followed by ART stimulation.
Number of subjects: 42
Study 34370858 — intervention group
Group type: COMPARATOR
Intervention: Control group underwent ART stimulation in a classical long agonist protocol using oral contraceptives.
Number of subjects: 42
Study 34370858 — intervention group
Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 42
Study 34370858 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultra-long group (I)
Number of subjects: 42
Study 32881761 — intervention group
Group type: EXPERIMENTAL
Intervention: Paro robot (multisensory enrichment)
Number of subjects: 105
Study 32881761 — intervention group
Group type: EXPERIMENTAL
Intervention: Music (auditory enrichment)
Number of subjects: 105
Study 32881761 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 105
Study 36320646 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac CTA
Number of subjects: 44
Study 36320646 — intervention group
Group type: COMPARATOR
Intervention: Echocardiography
Number of subjects: 44
Study 36320646 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 44
Study 33035687 — intervention group
Group type: EXPERIMENTAL
Intervention: c-terminal FGF23 (cFGF23) levels
Number of subjects: 172
Study 33035687 — intervention group
Group type: EXPERIMENTAL
Intervention: intact FGF23 (iFGF23) levels
Number of subjects: 172
Study 33035687 — intervention group
Group type: EXPERIMENTAL
Intervention: Longitudinal outcomes
Number of subjects: 172
Study 33046514 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemoradiotherapy (nCRT)
Number of subjects: 106
Study 32443343 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice-weekly MHD
Number of subjects: 140
Study 32443343 — intervention group
Group type: COMPARATOR
Intervention: 3-times-weekly MHD
Number of subjects: 140
Study 36058996 — intervention group
Group type: EXPERIMENTAL
Intervention: Passeo-18 Lux DCB (Biotronik)
Number of subjects: 302
Study 36058996 — intervention group
Group type: COMPARATOR
Intervention: IN.PACT Admiral DCB (Medtronic)
Number of subjects: 302
Study 34346046 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine 20mg/daily
Number of subjects: 60
Study 34346046 — intervention group
Group type: COMPARATOR
Intervention: Solifenacin 10mg/daily
Number of subjects: 60
Study 32715455 — intervention group
Group type: EXPERIMENTAL
Intervention: Vacuum‐assisted Access Sheath (VAAS) combined with holmium laser lithotripsy
Number of subjects: 76
Study 32715455 — intervention group
Group type: COMPARATOR
Intervention: Amplatz sheath combined with Cyberwand double probe ultrasound lithotripsy
Number of subjects: 76
Study 35346339 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flow nasal therapy for a minimum of 16 hours immediately post extubation
Number of subjects: 850
Study 35346339 — intervention group
Group type: COMPARATOR
Intervention: Standard oxygen therapy for a minimum of 16 hours immediately post extubation
Number of subjects: 850
Study 35346339 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flow nasal therapy
Number of subjects: 850
Study 35346339 — intervention group
Group type: COMPARATOR
Intervention: Standard oxygen therapy
Number of subjects: 850
Study 33662489 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose intermittent vitamin D3 supplementation
Number of subjects: 0
Study 33662489 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose B12 supplementation
Number of subjects: 0
Study 33662489 — intervention group
Group type: COMPARATOR
Intervention: Control group (dietary instruction only)
Number of subjects: 0
Study 33662489 — intervention group
Group type: EXPERIMENTAL
Intervention: Observational group (normal vitamin D and B12 levels)
Number of subjects: 0
Study 34740538 — intervention group
Group type: EXPERIMENTAL
Intervention: L-Carnitine 50 mg/kg
Number of subjects: 24
Study 34740538 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 36036539 — intervention group
Group type: EXPERIMENTAL
Intervention: Efgartigimod (FcRn antagonist)
Number of subjects: 17
Study 33098171 — intervention group
Group type: EXPERIMENTAL
Intervention: Millard technique for lip repair, von Langenbeck technique for palate repair, early palate repair (9 to 12 months)
Number of subjects: 448
Study 33098171 — intervention group
Group type: COMPARATOR
Intervention: Spina technique for lip repair, Furlow technique for palate repair, late palate repair (15 to 18 months)
Number of subjects: 448
Study 34750197 — intervention group
Group type: EXPERIMENTAL
Intervention: Prehabilitation program plus ERAS standard preoperative care
Number of subjects: 194
Study 34750197 — intervention group
Group type: COMPARATOR
Intervention: ERAS standard preoperative care
Number of subjects: 194
Study 32818963 — intervention group
Group type: EXPERIMENTAL
Intervention: VT‐1161 300 mg once daily for 3 days
Number of subjects: 55
Study 32818963 — intervention group
Group type: EXPERIMENTAL
Intervention: VT‐1161 600 mg once daily for 3 days
Number of subjects: 55
Study 32818963 — intervention group
Group type: EXPERIMENTAL
Intervention: VT‐1161 600 mg twice daily for 3 days
Number of subjects: 55
Study 32818963 — intervention group
Group type: COMPARATOR
Intervention: Fluconazole 150 mg (single dose)
Number of subjects: 55
Study 32677486 — intervention group
Group type: EXPERIMENTAL
Intervention: Swiss-roll folding method
Number of subjects: 100
Study 32677486 — intervention group
Group type: COMPARATOR
Intervention: Common folding method
Number of subjects: 100
Study 33567901 — intervention group
Group type: EXPERIMENTAL
Intervention: Relationship distress
Number of subjects: 0
Study 32196968 — intervention group
Group type: COMPARATOR
Intervention: Nutrition intervention arms (N)
Number of subjects: 0
Study 32196968 — intervention group
Group type: COMPARATOR
Intervention: Water intervention arm (W)
Number of subjects: 0
Study 32196968 — intervention group
Group type: COMPARATOR
Intervention: Control arm (C)
Number of subjects: 0
Study 32929891 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin 250 mg, 3 times per week for 16 weeks
Number of subjects: 128
Study 32929891 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128
Study 32929891 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin 250 mg, 3 times per week for 16 weeks (in AERD-negative patients)
Number of subjects: 128
Study 32929891 — intervention group
Group type: COMPARATOR
Intervention: Placebo (in AERD-negative patients)
Number of subjects: 128
Study 32942967 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical data model
Number of subjects: 100
Study 32942967 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical + electroencephalography data using deep learning neural network model
Number of subjects: 100
Study 35236423 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat milk fortified with 1500 IU nano-encapsulated vitamin D3 (200 mL/day)
Number of subjects: 289
Study 35236423 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat yogurt fortified with 1500 IU nano-encapsulated vitamin D3 (150 g/day)
Number of subjects: 289
Study 35236423 — intervention group
Group type: COMPARATOR
Intervention: Simple milk (200 mL/day)
Number of subjects: 289
Study 35236423 — intervention group
Group type: COMPARATOR
Intervention: Simple yogurt (150 g/day)
Number of subjects: 289
Study 32494991 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist-administered deprescribing intervention
Number of subjects: 45
Study 32494991 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 45
Study 36270632 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraperitoneal local anesthetic (IPLA)
Number of subjects: 150
Study 36270632 — intervention group
Group type: EXPERIMENTAL
Intervention: Local anesthetic wound infiltration (LWI)
Number of subjects: 150
Study 36270632 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study 33905144 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous nerve field stimulation in combination with optimized medical management
Number of subjects: 0
Study 33905144 — intervention group
Group type: COMPARATOR
Intervention: Optimized medical management alone
Number of subjects: 0
Study 32302526 — intervention group
Group type: EXPERIMENTAL
Intervention: SGLT-2 inhibitors
Number of subjects: 0
Study 32302526 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33894725 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduning injection (20 mL/day for 14 days)
Number of subjects: 157
Study 33894725 — intervention group
Group type: COMPARATOR
Intervention: Control (routine treatment without Reduning injection)
Number of subjects: 157
Study 33894725 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduning injection
Number of subjects: 157
Study 33894725 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 157
Study 34586006 — intervention group
Group type: EXPERIMENTAL
Intervention: Endotracheal tube cuff pressure maintained at 20 mmHg (Intervention Group)
Number of subjects: 98
Study 34586006 — intervention group
Group type: COMPARATOR
Intervention: Passive monitoring of endotracheal tube cuff pressure (Control Group)
Number of subjects: 98
Study 33764833 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg or 100 mg of water-soluble CoQ10 (total daily dose, 100 mg [n = 5] or 200 mg [6])
Number of subjects: 30
Study 33764833 — intervention group
Group type: COMPARATOR
Intervention: Placebo (7)
Number of subjects: 30
Study 34642106 — intervention group
Group type: EXPERIMENTAL
Intervention: Thought Field Therapy (single session)
Number of subjects: 50
Study 34642106 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group (no intervention)
Number of subjects: 50
Study 34848519 — intervention group
Group type: EXPERIMENTAL
Intervention: Rolling-refresher group (RRG) participated in very brief (5 min) rolling-refreshers every 4 months.
Number of subjects: 472
Study 34848519 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard group (SG) received one 50 min retraining session 1 year later.
Number of subjects: 472
Study 34848519 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) did not receive any additional training.
Number of subjects: 472
Study 34848519 — intervention group
Group type: EXPERIMENTAL
Intervention: Rolling-refresher group (RRG)
Number of subjects: 472
Study 32991462 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal morphine (0.1 mg)
Number of subjects: 80
Study 32991462 — intervention group
Group type: COMPARATOR
Intervention: Local infiltration anesthesia (LIA) with epinephrine, ketorolac acid, and ropivacaine
Number of subjects: 80
Study 32991462 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal morphine
Number of subjects: 80
Study 32991462 — intervention group
Group type: COMPARATOR
Intervention: Local infiltration anesthesia (LIA)
Number of subjects: 80
Study 34861430 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium (1000 mg/d) and Vitamin D (1000 IU/d) supplementation
Number of subjects: 100
Study 34861430 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 34243767 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical simulations with simulated patients (SP)
Number of subjects: 42
Study 34243767 — intervention group
Group type: EXPERIMENTAL
Intervention: Role-playing (RP) scenario
Number of subjects: 42
Study 34243767 — intervention group
Group type: COMPARATOR
Intervention: Both groups (SP and RP)
Number of subjects: 42
Study 35277034 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (3 mg/kg body mass)
Number of subjects: 22
Study 35277034 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 34793441 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg iOWH032 every 8 hours for 3 days
Number of subjects: 47
Study 34793441 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study 34164873 — intervention group
Group type: EXPERIMENTAL
Intervention: Enforcement methodology (Authorised Inspectors)
Number of subjects: 200
Study 34164873 — intervention group
Group type: EXPERIMENTAL
Intervention: Information and assistance methodology (general health service staff)
Number of subjects: 200
Study 34164873 — intervention group
Group type: EXPERIMENTAL
Intervention: Enforcement methodology (groups of smokers)
Number of subjects: 200
Study 34164873 — intervention group
Group type: EXPERIMENTAL
Intervention: Enforcement methodology (individual smokers)
Number of subjects: 200
Study 34164873 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall aggression measures
Number of subjects: 200
Study 34089515 — intervention group
Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT) with erythrosine, 15 min incubation, 15 min continuous light irradiation
Number of subjects: 18
Study 34089515 — intervention group
Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT) with erythrosine, 2 min incubation, 15 min continuous light irradiation
Number of subjects: 18
Study 34089515 — intervention group
Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT) with erythrosine, 15 min incubation, fractionated light (5 x 30 sec)
Number of subjects: 18
Study 34089515 — intervention group
Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT) with erythrosine, 2 min incubation, fractionated light (5 x 30 sec)
Number of subjects: 18
Study 35978368 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuing ACEIs/ARBs including on the day of surgery (group A)
Number of subjects: 2100
Study 35978368 — intervention group
Group type: COMPARATOR
Intervention: Withholding ACEIs/ARBs 24–36 hours before surgery (group B)
Number of subjects: 2100
Study 35978368 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuing ACEIs/ARBs (group A)
Number of subjects: 2100
Study 35978368 — intervention group
Group type: COMPARATOR
Intervention: Withholding ACEIs/ARBs (group B)
Number of subjects: 2100
Study 34432293 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorpromazine and/or haloperidol
Number of subjects: 81
Study 34432293 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregivers' preferred sedation (RASS scores of -1 to -2)
Number of subjects: 81
Study 34432293 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurses' preferred sedation (RASS score of -3)
Number of subjects: 81
Study 34432293 — intervention group
Group type: EXPERIMENTAL
Intervention: Deeper sedation preference by nurses
Number of subjects: 81
Study 34432293 — intervention group
Group type: COMPARATOR
Intervention: Caregivers vs. nurses sedation preference
Number of subjects: 81
Study 32962049 — intervention group
Group type: EXPERIMENTAL
Intervention: Leisure time physical activity (LTPA) - sedentary (0–149 min/week)
Number of subjects: 237
Study 32962049 — intervention group
Group type: EXPERIMENTAL
Intervention: Leisure time physical activity (LTPA) - moderately active (150–299 min/week)
Number of subjects: 237
Study 32962049 — intervention group
Group type: EXPERIMENTAL
Intervention: Leisure time physical activity (LTPA) - very active (300+ min/week)
Number of subjects: 237
Study 32962049 — intervention group
Group type: COMPARATOR
Intervention: Occupational groups (physical demands)
Number of subjects: 237
Study 36125620 — intervention group
Group type: EXPERIMENTAL
Intervention: Scheduled cystoscopy (group 1)
Number of subjects: 160
Study 36125620 — intervention group
Group type: COMPARATOR
Intervention: Immediate cystoscopy (group 2)
Number of subjects: 160
Study 33993346 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulization of 1 µg/kg dexmedetomidine (DEX) diluted in 4 mL 0.9% saline twice daily
Number of subjects: 43
Study 33993346 — intervention group
Group type: COMPARATOR
Intervention: Nebulization of 4 mL 0.9% saline
Number of subjects: 43
Study 33783878 — intervention group
Group type: EXPERIMENTAL
Intervention: 1064-nm picosecond Nd:YAG laser
Number of subjects: 106
Study 33783878 — intervention group
Group type: COMPARATOR
Intervention: 532/1064-nm picosecond Nd:YAG laser
Number of subjects: 106
Study 33783878 — intervention group
Group type: EXPERIMENTAL
Intervention: Both lasers
Number of subjects: 106
Study 33243153 — intervention group
Group type: EXPERIMENTAL
Intervention: Hearing aids
Number of subjects: 180
Study 33243153 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 180
Study 35180505 — intervention group
Group type: EXPERIMENTAL
Intervention: RehaCom computerized rehabilitation program (10 sessions of 45 minutes each over 5 weeks)
Number of subjects: 40
Study 35180505 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 40
Study 34865334 — intervention group
Group type: COMPARATOR
Intervention: Electroacupuncture
Number of subjects: 60
Study 34865334 — intervention group
Group type: EXPERIMENTAL
Intervention: Thunder-fire moxibustion combined with electroacupuncture
Number of subjects: 60
Study 35101723 — intervention group
Group type: EXPERIMENTAL
Intervention: Water-based treadmill walking training
Number of subjects: 60
Study 35101723 — intervention group
Group type: COMPARATOR
Intervention: Land-based treadmill walking training
Number of subjects: 60
Study 32354298 — intervention group
Group type: EXPERIMENTAL
Intervention: PIP-guided intracuff pressure modulation
Number of subjects: 120
Study 32354298 — intervention group
Group type: COMPARATOR
Intervention: Fixed intracuff pressure of 60 cmH2O (Control)
Number of subjects: 120
Study 35536061 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood group O+
Number of subjects: 360
Study 35536061 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood group A+
Number of subjects: 360
Study 35536061 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood group AB-
Number of subjects: 360
Study 35536061 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood group O phenotype
Number of subjects: 360
Study 35536061 — intervention group
Group type: COMPARATOR
Intervention: ABO blood type
Number of subjects: 360
Study 32678082 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous auricular vagus nerve stimulation (taVNS) on the left ear
Number of subjects: 0
Study 32678082 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous auricular vagus nerve stimulation (taVNS) on the right ear
Number of subjects: 0
Study 32678082 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 0
Study 34477171 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based rehabilitative program (HBP) group
Number of subjects: 17